Previous Section
Anaplastic Thyroid Carcinoma
1. Prognostic factors of anaplastic thyroid carcinoma.
- Author
- Jiang JY; Tseng FY;
- Institution
- Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei County, Taiwan.
- Journal
- J Endocrinol Invest. 2006 Jan;29(1):11-7.
- Abstract URL
- Click here to view abstract
2. Combining a matrix metalloproteinase inhibitor, a farnesyltransferase inhibitor, and a taxane improves survival in an anaplastic thyroid cancer model.
- Author
- She M; Jim Yeung SC;
- Institution
- Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
- Journal
- Cancer Lett. 2006 Jul 18;238(2):197-201. Epub 2005 Sep 8.
- Abstract URL
- Click here to view abstract
3. PET/CT staging and posttherapeutic monitoring of anaplastic thyroid carcinoma.
- Author
- Nguyen BD; Ram PC;
- Institution
- Department of Radiology, Mayo Clinic, Scottsdale, AZ 85259, USA. nguyen.ba@mayo.edu
- Journal
- Clin Nucl Med. 2007 Feb;32(2):145-9.
4. Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years.
- Author
- Brignardello E; Gallo M; Baldi I; Palestini N; Piovesan A; Grossi E; Ciccone G; Boccuzzi G;
- Institution
- Oncological Endocrinology Unit, San Giovanni Battista Hospital, Turin, Italy.
- Journal
- Eur J Endocrinol. 2007 Apr;156(4):425-30.
- Abstract URL
- Click here to view abstract
